Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Merli

Showing results (161-170 of 164) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 164 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2014
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana LinfomiL Arcaini, D Vallisa, S Rattotti, et al.
Journal of Viral Hepatitis|April 4, 2017
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitisR Vukotic, F Conti, S Fagiuoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2024
Corrigendum to "Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma": [Ann Oncol 35 (2024) 1039-1047]T M Kim, M Taszner, S Novelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2024
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphomaT M Kim, M Taszner, S Novelli, et al.
Pageof 17

Showing results (161-170 of 164) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 164 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2014
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana LinfomiL Arcaini, D Vallisa, S Rattotti, et al.
Journal of Viral Hepatitis|April 4, 2017
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitisR Vukotic, F Conti, S Fagiuoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2024
Corrigendum to "Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma": [Ann Oncol 35 (2024) 1039-1047]T M Kim, M Taszner, S Novelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2024
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphomaT M Kim, M Taszner, S Novelli, et al.
Pageof 17